| Similar Articles |
 |
Managed Care November 2007 Martin Sipkoff |
PBMs Agree to Disclose What They Pay for Drugs Pharmacy benefit managers will charge employers a straight administrative fee, rather than make much of their income through deals with the drug industry.  |
Managed Care September 2006 Martin Sipkoff |
PBMs Raise the Curtain Efforts are under way to find out exactly how pharmacy benefit managers work their magic.  |
The Motley Fool November 3, 2010 Brian Orelli |
A Generic Prescription for Double-Digit Growth MedcoHealth Solutions has it.  |
Managed Care March 2008 Martin Sipkoff |
PBMs' Rebate Income Threatened By Lawsuits and Move to Generics A recent court settlement may affect the way the PBM industry makes profits, but could it also lead to higher drug costs?  |
Managed Care July 2004 Maureen Glabman |
Wish List: 10 Things You Want From Your PBM One auditor estimates that 3 percent to 10 percent of pharmacy benefit manager (PBM) claims are processed incorrectly -- always in favor of the PBM.  |
The Motley Fool February 28, 2005 Brian Gorman |
Medco Covers Its Bases Medco's purchase of Accredo is a nod to future growth in biotech drug spending.  |
Managed Care March 2005 MargaretAnn Cross |
Transparency Catches Eye In Coalition's Deal With Medco A consortium of employers is paying the pharmacy benefit manager a new administration fee but taking all rebates and discounts.  |
The Motley Fool April 19, 2011 Bryan White |
Rising Star Buy: Medco Health Medco has a much brighter future than its current stock price implies.  |
The Motley Fool July 29, 2004 Brian Gorman |
Express Scripts' Bad Day Express Scripts joins other pharmacy benefit managers (PBM) embroiled in legal controversy. But the company, and its competitors, will eventually emerge from the fray and their stocks may then be worth another look.  |
CFO March 1, 2012 David McCann |
Companies May Win This Drug War The conflict between Express Scripts and Walgreen just might lead to lower drug-benefit costs for companies.  |
BusinessWeek May 9, 2005 Weintraub & Barrett |
BW 50: Can Caremark's Health Hold Up? Caremark Rx Inc. faces a growing set of legal and market challenges, but Its drug-benefit business is soaring, and its CEO remains upbeat about the future.  |
The Motley Fool June 13, 2005 Brian Gorman |
Walgreen Strikes Back The traditional drugstore operator is expanding its mail-order business. This should be a welcome sign to investors.  |
Managed Care December 2001 Steven S. Martin |
PBM Industry Today: Who's Managing Drug Costs? Health plans need to take a closer look. HMOs and employers alike will feel increasing pressure to give in to the desires of consumers...  |
Managed Care June 2005 |
PBMs Get Thumbs up From Satisfied Customers Pharmacy benefit managers that educate physicians on the safety and efficacy of generic drugs or provide them with generic drug samples to increase the use of generics get higher satisfaction ratings than those that don't.  |
The Motley Fool July 27, 2004 Brian Gorman |
Medco's Pumped About Generics Generic drugs are actually helping improve Medco's margins, making it a winner with investors and health-care plans.  |
Managed Care September 2002 John Carroll |
When Success Sours: PBMs Under Scrutiny Pharmacy benefit managers are under fire from many corners. What will the push for transparency mean for the industry?  |
The Motley Fool June 12, 2006 Brian Gorman |
Biogeneric Payoff? A new report indicates that spending on specialty drugs increased 17.5% in 2005. This growth bodes well for makers of biotech drugs, which make up a large portion of the specialty drug category. Investors, take note.  |
Managed Care January 2001 |
Express Scripts' Formulary Rulings To Go Online The public will have a chance to see what until now has been, mostly, understood only by managed care insiders: how a prescription drug winds up on a formulary...  |
The Motley Fool February 14, 2005 Brian Gorman |
GM Pulls Out of Walgreen The pharmacy's mail-order policy spurs the automaker's cost-containment decision.  |
Pharmaceutical Executive February 1, 2014 Jill Wechsler |
Drug Coverage, Costs Under Scrutiny Benefits offered by insurance plans on health exchanges and through Medicare are raising concerns about patient access to needed therapies  |
Managed Care September 2005 |
Headlines On Deadline ... WellPoint and Cigna are turning heads in the financial world... California health insurers have marked Jan. 1, 2007 on their calendars... etc.  |
The Motley Fool October 22, 2010 Roger Friedman |
3 Health-Care Stocks for Your Watchlist There's money to be made in health care. But finding the right plays, especially among health care providers, can prove confounding.  |
The Motley Fool November 2, 2006 Ryan Fuhrmann |
CVS Blazes a New Healthcare Trail Strong third-quarter earnings aside, the merger announcement with pharmacy benefit manager Caremark was the real shocker here. Investors, take note.  |
The Motley Fool December 19, 2006 Matthew Crews |
Express Scripts' Takeover Battle The pharmacy benefits manager challenges CVS with a higher bid for rival Caremark RX. Investors, stay tuned -- this is far from over.  |
Managed Care August 2002 Madeleine A. Estabrook |
Regulators Take More Interest In Role of PBMs in Health Care In a highly regulated industry such as health care, it is just a matter of time before every component of the industry comes under scrutiny and review. Pharmacy benefit managers are taking center stage now.  |
The Motley Fool July 30, 2009 Brian Orelli |
A Good Business Model for Bad Times Some businesses benefit when people are hurting. It's a beautiful time to be a pharmacy benefit manager, since that business model essentially results in them making more money when their customers save money.  |
BusinessWeek January 21, 2010 John Carey |
Making Personalized Medicine Pay Medco and other pharmacy benefit managers say future profits depend on matching drugs to patients based on their genes.  |
The Motley Fool June 30, 2011 David Williamson |
Pharmacy Benefits Delivering Drama CVS claims another Medco client and one messy split.  |
The Motley Fool October 28, 2010 |
Our Top Stock Idea Our investing community's latest prime pick -- Medco Health Solutions.  |
The Motley Fool October 24, 2006 Brian Gorman |
Medco's Fringe Benefits Recent developments will present some challenges, but Medco remains a solid long-term investment.  |
Managed Care October 2003 |
Medco Health Solutions tops consumer survey The 2003 WilsonRx Survey reports that patients have identified Medco Health Solutions as the top pharmacy benefit manager for the third year in a row.  |
Managed Care November 2005 John Carroll |
FTC Report Arms PBMs In Battle With Drugstores Congress passed the Medicare Modernization Act allowing pharmacy benefits managers to participate in Medicare Part D.  |
The Motley Fool February 22, 2005 Brian Gorman |
Novartis Embraces Generics The company is taking a different path from its branded pharmaceutical peers. The company's strategy may make its stock worth a closer look.  |
Pharmaceutical Executive October 1, 2008 Chris Biddle |
Stop the Bleeding Pharmaceutical manufacturers overpay pharmacy benefit managers millions of dollars each year in rebate overpayments. Here's how to stop the leakage.  |
Managed Care October 2005 |
Health Plans Pay Less When PBM Owns Mail-Order Pharmacy The ongoing debate on whether health plans pay more for drugs when using a mail-order pharmacy owned by a pharmacy benefits manager (PBM) or when the mail-order pharmacy is not owned by a PBM may be closer to resolution.  |
The Motley Fool February 16, 2005 Brian Gorman |
Medco's Double-Edged Sword The pharmacy benefit manager's latest financial report indicates that its business remains robust. But is it at the expense of retail pharmacies?  |
The Motley Fool August 16, 2010 Brian Orelli |
The Fine Line Between Saving Money and Making It Medco's trying to walk it.  |
The Motley Fool April 27, 2005 Brian Gorman |
Cautious on Medco Medco's earnings were respectable, but for now investors may want to step back.  |
The Motley Fool March 4, 2005 Tom Taulli |
In the Express Scripts Lane Express Scripts' strong results bring a much-needed lift to health-care investors.  |
BusinessWeek March 7, 2005 Amy Barrett |
A Drug Company On Growth Hormones By adding Accredo to its portfolio, Medco gains a strong presence in the area of specialty drugs. Investors sent Medco's stock down slightly on news of the deal. But they give company chief David B. Snow Jr. credit for putting Medco in a position to capitalize on new opportunities.  |
The Motley Fool November 19, 2010 Brian Orelli |
How to Get Rich Buying This Trend As the baby boomers get older, the number of medical procedures and drugs that the average American takes will increase.  |
The Motley Fool October 6, 2011 Dan Caplinger |
Has Medco Health Solutions Become the Perfect Stock? A lot has happened in the pharmacy benefits management space since we looked at Medco last year.  |
The Motley Fool March 26, 2010 Cathy Applefeld Olson |
Can CVS Caremark Win the Drug Wars? Now that health-care legislation has been signed into law, it's a perfect time to give the country's largest drugstore chain a checkup.  |
The Motley Fool November 8, 2006 Michael P. Cecil |
CVS/Caremark: A Brobdingnagian Drug Seller The merger of CVS and Caremark says a lot about pharmaceutical retailers and pharmacy benefit mangers trying to deal with a rapidly changing paradigm.  |
The Motley Fool February 25, 2009 Brian Orelli |
The Best Kind of Generic Growth Pharmacy benefit managers profit from penny-pinchers.  |
The Motley Fool October 30, 2006 Brian Lawler |
Celgene: Drug Kingpin Trading at 129 times trailing-12-month adjusted earnings, the biopharmaceutical looks ridiculously expensive, until one considers its awesome sales and earnings growth in that time period. Investors, take note.  |
The Motley Fool November 4, 2009 Brian Orelli |
This One Is Thriving in a Recession Saving customers money makes it easy for Medco.  |
The Motley Fool July 25, 2011 Brian Orelli |
Express-Medco: Just What the Doctor Prescribed In perhaps the most obviously beneficial merger ever, Express Scripts announced its plan to buy Medco Health Solutions for $29.1 billion.  |
Managed Care December 2003 Tony Berberabe |
Why Do FEHBP and Big Unions Excel at Managing Drug Costs? Pharmacy benefit managers can do only so much to keep drug price increases in the single digits. Initiatives instituted by health plans can help in this effort.  |
The Motley Fool April 30, 2008 Brian Orelli |
Medco's Far-From-Generic Quarter Pharmacy benefit manager Medco Health Solutions benefits from new generic drugs.  |